Transfusion bag for radiopharmaceuticals

By designing a radioactive drug infusion bag with radiation-proof shell and EVA soft bag, the radiation damage and leakage problems during radioactive drug infusion process is solved, and the safe storage and transportation of drugs are achieved, ensuring the safety and efficiency of the infusion process.

CN222075550UActive Publication Date: 2024-11-29SHANGHAI SHENGHENG BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202323500243.5
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-21
Publication Date
2024-11-29
Estimated Expiration
2033-12-21

AI Technical Summary

Technical Problem

During the infusion of radionuclide drugs, there is a risk of radiation damage to the body surface of medical personnel and patients, and radioactive drugs are prone to leak during storage and transportation, and there is a lack of effective protection and protective measures.

Method used

A radiopharmaceutical infusion bag with radiation-proof shell, EVA soft bag and PVC hose is designed. The shell has anti-radiation protection, pressure adjustment and humidity indication functions. The soft bag has built-in sponge to prevent shock cushioning and absorb leakage. , the hose is equipped with a dropper and flow rate adjustment clip to ensure safe infusion.

Benefits of technology

It significantly reduces the radiation damage caused by radioactive drugs to medical staff and patients, ensures the safe storage and transportation of drugs, provides anti-shock and leakage absorption functions, making the infusion of alpha-ray drugs safer and more efficient.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222075550U_ABST
    Figure CN222075550U_ABST
Patent Text Reader

Abstract

An infusion bag for radiopharmaceuticals relates to a medical infusion bag, is used for safely infusing the radiopharmaceuticals releasing alpha rays into the body of a patient, and comprises a shell, a soft bag, a hose and a needle head, the shell is a rigid anti-radiation protective shell and is made of aluminum or anti-radiation plastic with the thickness of 3mm to 10mm, a hanging ring B is arranged above the outer part of the shell, and a needle head is arranged on the soft bag. A pressure adjusting plug, an opening plug and a transparent window are arranged on the shell, and a soft bag fixing buckle, a humidity indicating card and sponge are arranged in the shell. According to the utility model, the radiation injury of radiopharmaceuticals to the body surfaces of medical personnel and patients can be greatly reduced, the functions of shock absorption, buffering and leaked liquid absorption are realized, the radiopharmaceuticals can be stored, transported and used more safely, and the radionuclide-coupled antibody medicine release device is light and is particularly suitable for radionuclide-coupled antibody medicines for releasing alpha rays.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to a medical infusion bag, more specifically, to an infusion bag for radioactive medicine. Background Art

[0002] Radionuclide drug conjugates (RDC) are an emerging type of tumor precision-targeted drug that uses tumor antigen-specific molecular carriers to deliver different radionuclides to tumor cells for diagnosis and treatment. 177 Lu-PSMA-617 and 177 The approval of Lu-Dotatate for marketing has set off a wave of RDC research at home and abroad, and ushered in an era of using radionuclide drugs for precise diagnosis and treatment of tumors.

[0003] In the in vivo drug radiotherapy of tumors, the beta rays or alpha rays emitted by radioactive isotopes are mainly used, and the nuclides used do not emit or emit less gamma rays to improve the treatment effect. Generally speaking, the energy of the radioactive nuclide rays used for treatment should be less than 1Mev for beta and less than 6Mev for alpha; the half-life should be between 1 and 10 days to take into account both effectiveness and safety. 177 Lu is the most commonly used radionuclide for RDC, which produces beta particle radiation with a half-life of 6.7 days and is suitable for the removal of small tumors and metastases. 225 Ac has gradually entered the clinic in recent years. It produces alpha particle radiation with a half-life of 9.9 days. Compared with beta radiation, alpha radiation has a larger particle mass, stronger killing ability, and a narrower penetration range. Combined with PSMA highly specific antibodies, alpha radiation can achieve a stronger therapeutic effect and has a smaller impact on normal tissues. Therefore, compared with 177 Lu has the characteristics of reducing toxicity and increasing efficacy.

[0004] RDC therapy combines radionuclides with specific monoclonal antibodies, achieving the dual advantages of precise targeting and potent killing of tumor cells. It can highly concentrate the energy released by radionuclides within a range of several times the diameter of cancer cells, thereby minimizing damage to surrounding normal tissues. This allows it to effectively kill cancer cells while protecting normal tissues, so it has good efficacy and low adverse reactions, and has broad application prospects in the treatment of malignant tumors. Summary of the invention

[0005] The utility model provides a radioactive drug infusion bag, which is used for safely infusing the radioactive drug releasing alpha rays into the patient's body.

[0006] The technical solution of the utility model is:

[0007] A radioactive drug infusion bag comprises a shell (1), a soft bag (2), a hose (3), and a needle (4).

[0008] The shell (1) is a rigid radiation-proof protective shell made of aluminum or radiation-proof plastic, such as polyetheretherketone (PEEK), with a thickness of 3 mm to 10 mm. The soft bag (2) includes a bag body (21), a joint A (22) and a hanging ring A (23). The bag body (21) is made of EVA (ethylene-vinyl acetate copolymer).

[0009] A hanging ring B (11) is provided on the upper part of the outer shell. A pressure regulating plug (12), an opening plug (16), and a transparent window (17) are provided on the outer shell (1). A soft bag fixing buckle (13), a humidity indicator card (14), and a sponge (15) are provided inside the outer shell (1). The pressure regulating plug (12) and the opening plug (16) can isolate the air and liquid inside and outside the outer shell (1) when they are closed. When the pressure regulating plug (12) is pulled out, it can be ventilated to maintain the balance of pressure inside and outside and allow the liquid in the soft bag (2) to drip smoothly. When the opening plug (16) is pulled out, the connector A (22) of the soft bag is exposed from the outer shell (1), so that the connector A (22) can be connected to the hose (3). The soft bag fixing buckle (13) is connected to the hanging ring A (23) and is used to fix the position of the soft bag (2) in the outer shell (1). The humidity indicator card (14) is made of an organic substance that changes color with humidity, such as color-changing silica gel, or a composite humidity indicator card prepared by adding other substances to a polymer material as a carrier. The transparent window (17) is made of radiation-proof glass, such as leaded glass. The humidity indicator card (14) is closely attached to the transparent window (17), so that the user can understand whether there is leakage inside the housing (1) through the transparent window (17). The sponge (15) has the functions of shockproof buffering and absorbing leakage, thereby preventing the soft bag from breaking during storage and transportation and preventing the leakage of radioactive drugs.

[0010] The hose (3) is a plastic tube with a wall thickness of 3 mm to 5 mm, and is made of PVC (polyvinyl chloride) or EVA. The upper end of the hose is provided with a connector B (31) for connecting to the connector A (22) of the soft bag (2). The hose is also provided with a dropper (32), a flow rate adjustment clamp (33) and other devices. The lower end is connected to the needle (4).

[0011] The method of using the utility model is:

[0012] The radioactive drug is poured into the soft bag (2), the joint A (22) is sealed, and then the soft bag (2) is placed in the shell (1), the hanging ring A (23) is connected with the buckle (13), the joint A (22) is inserted into the opening plug (16), the pressure regulating plug (12) is pressed down and placed in a closed state, and the shell (1) is closed to store or transport the drug.

[0013] When in use, the infusion bag containing the radioactive drug is taken out from storage, the opening plug (16) is pulled out to expose the interface A (22) to the outside, then the connector B (31) is connected to the interface A (22), the pressure regulating plug (12) is pulled out, the hanging ring B (11) is hung on the infusion stand, and then intravenous infusion is performed on the patient.

[0014] The beneficial effect of the utility model is that it can greatly reduce the radiation damage of radioactive drugs to medical staff and patient's body surface, has the functions of shockproof buffering and leakage absorption, so that radioactive drugs can be stored, transported and used more safely, and is lightweight, and is especially suitable for radionuclide-coupled antibody drugs that release alpha rays. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 : Schematic diagram of the structure of an infusion bag (excluding the hose) for radioactive drugs.

[0016] Figure 2 : Schematic diagram of the structure of a radioactive drug infusion bag hose.

[0017] Figure numerals: 1-housing, 2-soft bag, 3-hose, 4-needle, 11-hanging ring B, 12-pressure regulating plug, 13-soft bag fixing buckle, 14-humidity indicator card, 15-sponge, 16-opening plug, 17-transparent window, 21-bag body, 22-connector A, 23-hanging ring A, 31-connector B, 32-dropper, 33-flow rate regulating clip. Implementation

[0018] Example 1: Structure of a radiopharmaceutical infusion bag

[0019] A radiopharmaceutical infusion bag ( Figure 1 , Figure 2 ), comprising a housing (1), a soft bag (2), a hose (3), and a needle (4).

[0020] The shell (1) is a rigid radiation protection shell with a thickness of 5 mm and is made of aluminum. The soft bag (2) comprises a bag body (21), a joint A (22) and a hanging ring A (23), and the bag body (21) is made of EVA (ethylene-vinyl acetate copolymer).

[0021] A hanging ring B (11) is provided on the upper part of the outer shell. A pressure regulating plug (12), an opening plug (16), and a transparent window (17) are provided on the outer shell (1). A soft bag fixing buckle (13), a humidity indicator card (14), and a sponge (15) are provided inside the outer shell (1). The pressure regulating plug (12) and the opening plug (16) can isolate the air and liquid inside and outside the outer shell (1) when they are closed. When the pressure regulating plug (12) is pulled out, it can be ventilated to maintain the balance of pressure inside and outside and allow the liquid in the soft bag (2) to drip smoothly. When the opening plug (16) is pulled out, the connector A (22) of the soft bag is exposed from the outer shell (1), so that the connector A (22) can be connected to the hose (3). The soft bag fixing buckle (13) is connected to the hanging ring A (23) and is used to fix the position of the soft bag (2) in the outer shell (1). The humidity indicator card (14) is made of organic color-changing silica gel that changes color with humidity, and the transparent window (17) is made of radiation-proof leaded glass. The humidity indicator card (14) is closely attached to the transparent window (17), so that the user can understand whether there is leakage inside the housing (1) through the transparent window (17). The sponge (15) has the functions of shockproof buffering and absorbing leakage, thereby preventing the soft bag from breaking during storage and transportation and preventing the leakage of radioactive drugs.

[0022] The hose (3) is a plastic tube with a wall thickness of 3 mm to 5 mm, made of PVC (polyvinyl chloride), with a connector B (31) at the upper end for connecting to the connector A (22) of the soft bag (2), a dropper (32), a flow rate adjustment clamp (33) and other devices, and the lower end is connected to the needle (4).

[0023] Example 2: Method for using a radiopharmaceutical infusion bag

[0024] The radioactive drug is poured into the soft bag (2), the joint A (22) is sealed, and then the soft bag (2) is placed in the shell (1), the hanging ring A (23) is connected with the buckle (13), the joint A (22) is inserted into the opening plug (16), the pressure regulating plug (12) is pressed down and placed in a closed state, and the shell (1) is closed to store or transport the drug.

[0025] When in use, the infusion bag containing the radioactive drug is taken out from storage, and the humidity indicator card (14) is first observed through the transparent window (17) to see if it changes color. If it changes color, it indicates that leakage may occur inside. After confirming that there is no color change, the opening plug (16) is pulled out to expose the interface A (22) to the outside, and then the connector B (31) of the hose (3) is connected to the interface A (22), the pressure regulating plug (12) is pulled out, and the hanging ring B (11) is hung on the infusion stand, and then the patient is given intravenous infusion.

Claims

1. A radiopharmaceutical infusion bag, comprising a housing (1), a soft bag (2), a hose (3), and a needle (4), wherein: The shell (1) is a rigid radiation-proof protective shell, made of aluminum or radiation-proof plastic with a thickness of 3 mm to 10 mm. A hanging ring B (11) is provided on the upper part of the outer shell. The shell (1) is provided with a pressure regulating plug (12), an opening plug (16), and a transparent window (17). The inside of the shell (1) is provided with a soft bag fixing buckle (13), a humidity indicator card (14), and a sponge (15). The soft bag (2) includes a bag body (21), a joint A (22), and a hanging ring A (23).

2. The radiopharmaceutical infusion bag according to claim 1, characterized in that: The pressure regulating plug (12) and the opening plug (16) can isolate the air and liquid inside and outside the housing (1) when they are in the closed state. When the pressure regulating plug (12) is in the pulled-out state, it can be ventilated to maintain the pressure balance inside and outside and allow the liquid in the soft bag (2) to drip smoothly. After the opening plug (16) is pulled out, the connector A (22) of the soft bag will be exposed from the housing (1), so that the connector A (22) can be connected to the hose (3). The soft bag fixing buckle (13) is connected to the hanging ring A (23) and is used to fix the position of the soft bag (2) in the housing (1). The humidity indicator card (14) is closely attached to the transparent window (17), so that the user can understand the leakage situation inside the housing (1) through the transparent window (17).

3. The radiopharmaceutical infusion bag according to claim 1, characterized in that: The hose (3) is a plastic tube with a wall thickness of 3 mm to 5 mm. The upper end is provided with a connector B (31) for connecting to the connector A (22) of the soft bag (2). The hose (3) is also provided with a dropper (32) and a flow rate adjustment clamp (33). The lower end is connected to the needle (4).

4. The radiopharmaceutical infusion bag according to claim 1, characterized in that: The shell (1) is made of polyetheretherketone (PEEK), the humidity indicator card (14) is made of an organic substance that changes color with humidity, the transparent window (17) is made of radiation-proof glass, the bag body (21) is made of ethylene-vinyl acetate copolymer (EVA), and the hose (3) is made of polyvinyl chloride (PVC) or ethylene-vinyl acetate copolymer (EVA).